Abingdon Health is delighted to announce the appointment of Professor Mike Holmes BSc MB ChB MSc DRCOG FRCGP as a medical advisor to the company. Professor Holmes is recognised for his work for delivering at scale primary care across Yorkshire and the Humber; his experience will support the company’s work on developing tests for detection of antigens and antibodies to the SARS-CoV-2 virus.
Professor Holmes is currently the Vice Chair of the Royal College of General Practitioners with responsibility for their Membership and International work. He has been a Partner at Haxby Group since 2002 which is a large multi-site practice caring for over 60,000 patients across the cities of York and Hull.
Professor Holmes has interests in clinical leadership, addressing health inequalities and the development of a multi-professional workforce in primary care. He chairs the regional faculty of Advanced Clinical Practitioners and Physician Associates and he is an Honorary Professor in the Department of Health Sciences at the University of York.
Dr Chris Hand, Chairman of Abingdon Health commented, “we are delighted that Mike has agreed to work with on various projects relating to SARS-CoV-2 and COVID-19. Mike’s expertise in the primary care setting will be particularly useful as we work on diagnostic tests for this virus particularly in relation to our work with the UK-RTC to develop a COVID-19 antibody test”.
Dr Mike Holmes commented, “The work Abingdon Health is undertaking with the UK-RTC is going to provide self-tests to the UK population on a scale never seen before and will be invaluable for further understanding the effects of the SARS-CoV-2 infection. I look forward to working with the team on these projects.”
Abingdon Health is a technology-enabled lateral flow diagnostics company providing innovative rapid testing solutions to a multi-industry, global client base. Located across three UK sites, Abingdon Health boasts specialist assay development and a Smartphone reader division alongside Europe’s largest lateral flow test manufacturing capacity. By combining a multi-disciplinary approach with precision automation Abingdon Health assures product consistency and security of supply for the most complex of assays and markets. Abingdon Health takes projects from initial concept through scale-up and into high-volume manufacturing in addition to accommodating clients looking to transfer their rapid test from third-party developers or manufacturers.
Abingdon Health is headquartered in York, United Kingdom. Visit www.abingdonhealth.com.